Wave Life Sciences: WVE-007 Data Leaves Biotech Shaken And Stirred (Downgrade) [Seeking Alpha]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Seeking Alpha
WVE-007 demonstrated strong visceral fat reduction and muscle preservation, but failed to match GLP-1 agonists' headline weight loss, driving market disappointment. WVE management highlights potential for better results in higher BMI populations in Phase 2a, and positions WVE-007 as adjunct or maintenance therapy for GLP-1 users. Wave remains well-funded ($602m cash, runway into Q3 2028), with multiple pipeline catalysts in 2026, but near-term WVE upside appears limited after data miss. Looking for higher risk/reward options trading ideas? I offer this and much more at my exclusive investing ideas service, Haggerston BioHealth. Learn More » MSTORY/iStock via Getty Images Investment Overview: Wave Life Stock Tumbles On Obesity Data Release The stock of Wave Life Sciences Ltd. ( WVE ) is down 50% so far today, trading at a value of ~$6 at the time of writing (market More on my IG service If you are interested in keeping up to date with stocks making moves within the bio
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Is This Weight Loss Drug Stock a Buy on the Dip? [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Obesity Data Highlights Visceral Fat Focus Over Weight Loss [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Ltd. (WVE) PT Increased to $52 at Canaccord Following Pipeline Review [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Crashes Deep into Oversold Territory as Obesity Drug Data Disappoints. Should You Buy the Dip? [Yahoo! Finance]Yahoo! Finance
- WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks [Yahoo! Finance]Yahoo! Finance
WVE
Earnings
- 2/26/26 - Miss
WVE
Sec Filings
- 3/30/26 - Form SCHEDULE
- 3/30/26 - Form 4
- 3/26/26 - Form 4
- WVE's page on the SEC website